# Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT

> **NCT07143201** · PHASE2 · RECRUITING · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 26 (estimated)

## Conditions studied

- Patent Ductus Arteriosus
- Preterm

## Interventions

- **DRUG:** Standard Dose - Ibuprofen oral suspension
- **DRUG:** Precision Dose - Ibuprofen oral suspension

## Key facts

- **NCT ID:** NCT07143201
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-04
- **Primary completion:** 2026-07
- **Final completion:** 2027-07
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2025-08-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07143201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07143201, "Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07143201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*